It is well known in photodynamic therapy (PDT) that there is a large variability between PDT light dose and therapeutic outcomes. An explicit dosimetry model using apparent reacted 1 O 2 concentration ([ 1 O 2 ] rx ) has been developed as a PDT dosimetric quantity to improve the accuracy of the predicted ability of therapeutic efficacy. In this study, this explicit macroscopic singlet oxygen model was adopted to establish the correlation between calculated reacted [ 1 O 2 ] rx and the tumor growth using Photofrin-mediated PDT in a mouse tumor model. Mice with radiation-induced fibrosarcoma (RIF) tumors were injected with Photofrin at a dose of 5 mg/kg. PDT was performed 24h later with different fluence rates (50, 75 and 150 mW/cm 2 ) and different fluences (50 and 135 J/cm 2 ) using a collimated light applicator coupled to a 630nm laser. The tumor volume was monitored daily after PDT and correlated with the total light fluence and [ 
INTRODUCTION
Photodynamic therapy (PDT) is a relatively new therapeutic modality for certain cancers, precancerous diseases and benign diseases [1] [2] [3] . The mechanism of PDT is unique in that during PDT, the three elements, the photosensitizer, the oxygen, and the light, are dynamic changing and interacting. In a typical type II process, upon light activation, the excited photosensitizer will transfer energy to oxygen to produce singlet oxygen ( 1 O 2 ), resulting in cell death or survival, which is highly dependent on the amount of 1 O 2 [4] . Establishment a dosimetry metric based on cumulative singlet oxygen dose to predictive efficacy of PDT is of great importance for the safety and effectiveness of the clinical application of PDT, which is a very challenging and active area of study for PDT [5] [6] [7] . Direct 1 O 2 measurements based on the 1270 nm phosphorescence of 1 O 2 , called singlet oxygen luminescence dosimetry (SOLD) has shown promising result in in vitro studies, but in vivo it is very difficult due to the weak signal of singlet oxygen luminescence [8] . A microscopic model involves the dynamic interaction of the three components of PDT (the light, drug and oxygen) as well as the effect of the dynamic change of blood flow to these three elements. Although the mathematical model has shown improvement in predicting the PDT outcome in in vivo studies, it is still impossible in the clinical setting due to the complicated of describing the complete 3D tumor microvascular environment and the vast computational need. In order to facilitate the clinical practice, an explicit macroscopic singlet oxygen model was developed [9] . In this model, the light dose, in vivo photosensitizer concentration, the initial oxygen concentration and the tumor optical properties were all taken into account. Instead of 1 O 2 , an apparent reacted singlet oxygen , [ 1 O 2 ] rx , was proposed as the dosimetry quantity. In this study, the ability of the [ 1 O 2 ] rx as a dosimetric predictor for Photofrin-mediated PDT was evaluated in a mouse RIF tumor growth study.
MATERIALS AND METHODS

Macroscopic Singlet Oxygen Model
The aim of this section is to introduce the empirical macroscopic singlet oxygen model that was adopted in this study which can be simplified and expressed as following four PDT kinetic equations (1-4) [7] . This model was derived from reaction rate equations for a type II PDT mechanism. The derivation for these equations has been described in detail elsewhere [10, 11] .
( 1 )
Here, ϕ is the light fluence rate, S is the source term, μ α and μ s ' are the absorption and reduced scattering coefficients of the tumor tissue. ξ, σ, and β are three photochemical parameters. ξ represents the specific oxygen consumption rate, σ is the specific photobleaching ratio, and β is the oxygen quenching threshold concentration. δ is defined as the low centration correction of photosensitizer, and g is the maximum oxygen perfusion rate.
Determine the model parameters
The photochemical parameters β and δ were obtained from the literature [12, 13] , the other model parameters(σ, g, ξ and
were obtained from a former study by using two interstitial catheters to induce partial treatment [9] .
For tumor optical properties (μ α and μ s '), a central catheter in the tumor was used to insert a 2mm point source coupled to a 630 nm diode laser (Biolitec, Inc., East Longmeadow, MA, USA), the peripheral catheter placed 3 mm away contained an isotropic detector to collect the light fluence rate profile along the length of the tumor. Using light fluence data prior to PDT treatment, Eq. (1) for a point source is used to obtain μ α and μ s ' using a nonlinear optimization algorithm based on a diffusion theory model [14, 15] . Both the diffuse approximation method and the monte carlo method were used to simulate the spatial distribution of light fluence rate with measured optical property variation in mice ( Figure 1A ), as demonstrated in Figure 1B , the maximum variation between these two methods was ~25%.
The in vivo Photofrin concentration was obtained by measured fluorescence spectra and compared with phantoms studies with known Photofrin concentrations [16] . Figure 1 . Light fluence rate (φ) distribution due to RIF tumor optical properties (A) The ratio of the fluence at a tissue depth and at air (φ air ) versus the tumor depth. DA is the diffuse approximation simulation, while MC is the monte carlo simulation.
(B) Ratio of the DA mean fitting to the MC simulation, the maximum variation is ~25%.
Then PDT was performed with a serial of conditions to induce a partial treatment response. Radioactively induced fibrosarcoma (RIF) cells were injected subcutaneously into the right shoulders of 6-8 week old female C3H mice (NCI-Frederick, Frederic, MD) 5-10 days before PDT at a concentration of 3×10 5 cells/ml. When the tumors reached about 2-9 mm in diameter and 2-5 mm in height, PDT was performed. Before PDT, the fur in the irradiation area was depilated with Nair. 
is the amplitude and d represents the number of the days after PDT treatment. Tumor-bearing mice with neither light irradiation nor Photofrin were used as controls.
Statistical Analysis
Tumor growth factor of each condition is expressed as the mean ± standard deviation of the measurements. Before PDT, the tumor volumes in each of the two groups were compared using Kruskal-Wallis tests to find if there was any difference between each group. After PDT, Wilcoxon tests were used to evaluate whether the tumor growth rate in control and each PDT group had significantly different. Analyses were carried out using SPSS 22.0 software. Statistical significance was defined at p < 0.05 level (95% confidence level). Before PDT, the tumor volumes in each of the two groups had no significant difference from each other (p=0.448). Comparing with the control group, each PDT group had the ability to inhibit the tumor regrowth after PDT (p<0.05 for all). Among them, PDT at 135 J/cm 2 with a fluence rate of 75 mW/cm 2 reached complete cure, while partial tumor growth inhibition was found in all other PDT treatment conditions groups. Fluence (J/cm2) 
RESULTS AND DISCUSSION
B A
As for PDT light dose, PDT efficiency on tumor growth was varied with fluence and fluence rate ( Figure 4B ). For example, at the same fluence of 50 J/cm 2 with the fluence rate of 50, 75, and 150 mW/cm 2 , the tumor growth rate after PDT was at 0.31±0.02, 0.30±0.07 and 0.32±0.01, respectively. At the higher fluence of 135 J/cm 2 , among these three fluence rates, the highest tumor growth rate of was found at 150 mW/cm 2 , while the lowest tumor growth rate was with 75mW/cm 2 . While at the same fluence rate of 75mW/cm 2 , the tumor growth rate after PDT with a fluence of 50 and 135J/cm 2 was at 0.30±0.07 and 0, respectively. Furthermore, the linear fitting of fluence to the tumor growth rate showed the goodness of R 2 =0.71, which indicated that the poor relation between flucence and PDT efficiency.
Together, these preliminary results indicate that PDT light dose alone is not accurate to predict the PDT outcome, while [ 1 O 2 ] rx had a better relation with the PDT-induced tumor growth inhibition than that of PDT light dose. More PDT conditions with a wide range of PDT fluence and flucenc rate was well as a larger sample of mice will be needed to further verify the predictive ability of this macroscopic single oxygen model.
CONCLUSION
